Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients

被引:12
|
作者
Jiang, YongWei [1 ]
Ma, Liang [2 ,3 ]
Han, ChengWu [1 ]
Liu, Qian [1 ]
Cong, Xiao [1 ]
Xu, YaPing [4 ]
Zhao, TingTing [3 ]
Li, Ping [2 ,3 ]
Cao, YongTong [1 ]
机构
[1] China Japan Friendship Hosp, Clin Lab, Beijing, Peoples R China
[2] Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China
[4] China Japan Friendship Hosp, Inst Clin Med Sci, Dept Pathophysiol, Beijing, Peoples R China
关键词
E GENE POLYMORPHISM; RENAL-DISEASE; APOE POLYMORPHISM; KIDNEY-DISEASE; ASSOCIATION; PROGRESSION; MELLITUS; SUSCEPTIBILITY; POPULATION; METABOLISM;
D O I
10.1155/2017/3560920
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy (DN) is one of the major chronic complications of diabetes. Genetic polymorphism of Apolipoprotein E (ApoE) has been proposed to participating in DN. The purpose of the study was to evaluate the relationship between ApoE genetic polymorphism and the presence of DN in Chinese type 2 diabetic patients. We studied 845 diabetic patients who were divided into DN group (n = 429) and control group (n = 416). ApoE genotype was determined by ApoE genotyping chip and the plasmatic biochemical characterization was performed on all subjects. There were differences (P < 0.001) in HbA1c, creatinine, and urinary albumin between the two groups. The ApoE epsilon 2 allelic frequency was 7.69% in DN group versus 3.49% in control group (OR = 2.22, 95% CI = 1.41-3.47, and P < 0.05), as expected, ApoE E2/E2 and E2/E3 genotype frequency were higher in DN group (13.75% versus 6.49%, P < 0.05). The ApoE epsilon 4 allelic frequency was 7.93% in DN group versus 11.54% in control group (OR = 0.70, 95% CI = 0.50-0.97, and P < 0.05), and DN group presented a lower frequency of ApoE E3/E4 and E4/E4 genotype frequency (14.91% versus 19.96% P < 0.05). These results suggest ApoE epsilon 2 allele may be a risk factor; however ApoE epsilon 4 allele may play a protective role of DN in Chinese type 2 diabetic patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Correlations of creatine and six related pyrimidine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients
    Xia, Jian-Fei
    Hu, Ping
    Liang, Qiong-Lin
    Zou, Ting-Ting
    Wang, Yi-Ming
    Luo, Guo-An
    CLINICAL BIOCHEMISTRY, 2010, 43 (12) : 957 - 962
  • [22] Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients
    Sun, JH
    Xu, YC
    Zhu, YL
    Lu, HY
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 64 (03) : 185 - 190
  • [23] Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients
    Fu, Chen-Chung
    Wu, Du-An
    Wang, Ji-hung
    Yang, Wen-Chin
    Tseng, Chin-Hsiao
    ACTA DIABETOLOGICA, 2009, 46 (02) : 127 - 134
  • [24] Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients
    Chen-Chung Fu
    Du-An Wu
    Ji-hung Wang
    Wen-Chin Yang
    Chin-Hsiao Tseng
    Acta Diabetologica, 2009, 46
  • [25] Influence of apolipoprotein E genotype on progression of diabetic nephropathy
    Joss, N
    Jardine, A
    Gaffney, D
    Boulton-Jones, JM
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2005, 101 (04): : E127 - E133
  • [26] Effects of ginkgo biloba extract on prevention of development of diabetic nephropathy in type 2 diabetic patients
    Wang, Y.
    Sun, Z.
    Yu, J.
    Yang, B.
    Yin, H.
    Wang, Y.
    DIABETOLOGIA, 2012, 55 : S456 - S456
  • [27] Nephroprotective effects of diacylglycerol on diabetic nephropathy in type 2 diabetic rats
    Li, Jianpeng
    Yan, Yongheng
    Li, Duo
    Li, Xia
    Lin, Xinying
    Liu, Zhenhua
    Xu, Tongcheng
    Du, Fangling
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (02) : 1918 - 1926
  • [28] Renoprotective effects of low-dose valsartan in type 2 diabetic patients with diabetic nephropathy
    Suzuki, K
    Souda, S
    Ikarashi, T
    Kaneko, S
    Nakagawa, O
    Aizawa, Y
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 57 (03) : 179 - 183
  • [29] Progression of nephropathy in type 2 diabetic patients
    Rossing, K
    Christensen, PK
    Hovind, P
    Tarnow, L
    Rossing, P
    Parving, HH
    KIDNEY INTERNATIONAL, 2004, 66 (04) : 1596 - 1605
  • [30] PREVALENCE OF NEPHROPATHY IN TYPE 2 DIABETIC PATIENTS
    Marchetto, Rocio
    Zamer, Javier
    Agostini, Marcela
    REVISTA MEDICA DE ROSARIO, 2012, 78 (03): : 118 - 124